Member Info for dactions

Thinking of the effort a lot of members went to last week on the goings on with flights from Austria to Southampton - do we have any Sherlocks in our group that know how the two ladies on Phase II and Phase III got on ?

Phase 2 trial patient 20th May 2020 at University Hospital Southampton
Kay Flitney aged 67 who said:
"You don't notice you're taking it 'til you're finished. It's not so bad. I could see myself taking it at home."

Phase 3 trial 1st patient 13 Jan 2021 at Hull Royal Infirmary
Alexandra Constantin aged 34

Mikebassets - Thanks for the link

Excellent interview - Ken James is very clear in his comments and there is an exciting period ahead. I do wonder though why it takes quite so long to get started - he talked of 2nd half of year - especially when we know the FDA has asked for a 6 months duration. I guess I'm being impatient.

If they can get a commercial partner for EU/UK soon that will keep the sp bubbling and lessen my impatience re. the FDA - as word will get round soon enough once sales in EU/UK get started and men's performance turns out to be as good as we're led to believe.

Impatient yes.
Excited too.

I top sliced some of my long term holding this morning at 81p before the fast fallback because of my concerns that the IIs will be wanting to offload some shares and get some quick & easy profit.

Remember Lombard Odier has approx 20% holding, most of which will have been secured in the 2018 placing of 7p - and I'm expecting some sell-off from them this week, just like the relentless sales ahead of that time that they did when the sp was in the 30 - 40p range. Remember too they now have warrants to subscribe for new shares valued at just 40p.

Also, we have to be aware that the recent Chinese funding by Riverwood allows them to convert their loans at 30p and also buy 2.2m shares at 22p. In total, an additional 9.7 million shares likely to dilute our holdings.

The share price is moving back up again so it's looking OK for the moment, but it's worth bearing in mind that the IIs will also be looking to make a profit and often they're deals can be very lumpy and spoil it for the likes of us private investors.

That was last year's interview with Ken James. In my opinion, his voice at FUM has always been the more confidence-inspiring and the one who speaks more easily on the merits of the company's products. It's still worth a watch for those more recently holding shares and to understand the outstanding possibilities that now exist for the company's future.

Friday's Proactive interview complete's the picture - again with Ken James.
https://www.youtube.com/watch?v=yoFCZwkbPYs

Good luck everyone for a promising few weeks coming up.

GCCRa - can't agree with you at all - what's there to care about at least at current sp levels - perhaps if it were in ££s - besides I remember you were a keen buyer/holder of FUM shares !

The arguments are invalid:
- Viagra is yesterday's news - it's onset I'm told is up to an hour - it has some uncomfortable side-effects for many users. It's an unattractive pill.

- Kamagra - isn't legal in the UK/EU - Med3000 has been through all Phases I - III. This will be easily available at a low price point (I reckon max. £5).

- Production rights will happen fast - not least by the recent Chinese Licensees for their locale.

- And for good measure, FUM will not have to payback the recent £1.5million loan as that is likely to be converted into Equity if the sp holds above 30p (?) for the next month.

This has growth prospects written all over it.
Good luck GCCCa - keep hold of your existing FUM shares and if the sp quietens down in the next weeks, it could be worth teven thinking about topping up ?

Eccles - I think you've only recently bought into FUM - so well done indeed.
Mind you I'm hoping CHIEFS is right with his forecast sp ;-)

IDG69 - always a tricky one to know if averaging down works especially with AIM shares. Several of mine have bombed completely - but I did average down substantially on FUM so I'm grateful to get it right on this one.

But I reckon when the day traders lose interest and the sp settles down, they'll be a calm period before the next news allowing thoughts of topping up ?

Wilco999 - I think it's only you and me who has done really well on today's announcement. Being probably one of the longest holders on this BB, I saw your positive comments these past many months and you said you were adding so I hope you've done very well.

I first bought in some years back when it was trading around the 40p + mark and watched it sky-rocket to 80p + when the Daily Mail headlined 8th September 2016 'Viagra too slow for you ? Should have taken my profits then.

But I did buy into the 7p placing November 2018 and that sorted my average. It might be a bit wobbly in the days ahead but I reckon we're going to get more news in the weeks ahead and I'm going to let this run - I'm quite sure we'll be a lot further north than we are today in a few months time.

Excellent Proactive interview with Ken James of Futura - well worth a watch so you can assess the real potential of their product. The sky's the limit in many ways now over the counter approval is coming from the EU and thereby the UK too.

Regarding US sales, Ken James believes they'll be able to prove to the FDA that they'll get approval there too after running the 6 months trial against Cialis at its lower strength.

Glad I've held all these years. Good luck all.

Well Trurotrader - you made a good move cutting your losses - something I should have done with hindsight. But I agree Fox looks in an better position now than it did and hopefully they'll make the progress that we believe they can. Good luck.

"Chart is indicating strong chance of reversal at these levels could see quick move to 10p+"

Ark87 - if there's a quick move to 10p - all of us on this BB would beat you out of the door !

Wow Trurotrader - average of 2.1p
For all my toppings up in recent years, I still can't get below 5.3p :-(

I agree with TruroTrader - we might as well give up on Fox if we ignore their right to a legally obtained quarry. There is a new government in Kosovo - they aspire to joining the EU - as does it's neighbours, principally Serbia - so that won't be on if law & order goes out of the window. They want to grow the economy - as their current base level puts them down the list in meeting the EU's financial joining criteria.

The Americans were very supportive of Kosovo redevelopment - particularly its involvement in Stone Alliance and in which Fox in involved - I am sure that still applies to the new Bidon administration.

With these legal heavy hitters on board, I think there is a very much better than evens chance of at least seeing the sp increase - perhaps as much to 10p before the year is out. Others on this BB have worked out that just a small percentage of the claim being met would achieve that. I've invested at much higher levels than now as indeed has CG and his associates and we all want a decent return on our money and involvement. They have a first-class product and after all those years of waiting, a decent factory site so I continue to be very positive for a good outcome both for the Company and myself.

monsieur Aurelien Mary is a clinical pharmacist based in Amiens France. He has been aware of Synairgen since the early stages of the pandemic. I am quite sure he is very positive of the merits of SNG but in the absence of clearance to use it as it is now on a phase III trial, as we know, he is working on an alternative nebulised interferon treatment.

I understand we have the patents for such alternatives but id be happier if our trials could be concluded sooner.

SPred - thanks for article but it does show an error mentioning Synairgen’s test was on 1010 patients whereas it was only 101.

Disco man - thanks for links. I must admit I thought I watched FUM closely but never saw these last year.

Irrespective of recent share price gyrations, the facts are that a very good contract was negotiated last week especially when you consider it is the one area where we’d have been hard put to achieve good terms.

My only concern (being flippant ) is that one wag said he’d tried Vicks VapourRub and it worked for him :-)

Seriously - I’m sure we’ve turned a positive corner this time.

Thanks Goldust88 - there are a heck of a lot of doubters on this board today - goodness where do they come from - best to filter them I guess.

At last we're seeing some really positive news from FUM - as I think - Reflex - pointed out in another thread, the SP should have been far better than it is but for FUM. As far as I'm concerned that is all about the boss James Barder - where I feel he personally made mistakes. Things started to change when he and Ken James started to work together.

I am no scientist so I don't know whether anyone could have foreseen the errors in the 1000 person trial whereby it was concluded that the placebo itself ( i.e. the delivery agent Dermasys) was the successful agent.

The other point today, which I feel too many people joining this BB for the first time missed, is the complexity in setting up these foreign finance deals. Everyone has to feel they are getting something from it - it can't be all gravy for us FUM shareholders. Also, I don't believe the costs still needed to conclude EU and FDA approval will be significant.

On balance, this is a real turnaround point for FUM today and we can expect further good sp movement in the coming months.

As someone who bought in years ago at 30p in 2013 and before the Daily Mail press news of 2016 which sent it up to 80p +, I agree - darkyhorse - the market isn't yet seeing Futura's potential.

There is no way after today's announcement that this won't be anything other than a multi-bagger from here. I bought in on the last placing at 7p/8p which lowered my average right down and am going to ignore the sp swings and let it ride, confident that in a few months I'll be even happier.

Brilliant news - at last the real journey begins. We know dermasys works and we now have funding to move the company forward. I’ve waited years for this and happy to let it continue to run.

Good luck all

Brucejamieson - sorry must have missed it or was it when you were referring to being able to buy the product ?

I looked at the Companies House details on FUM's partner CBDerma Technology Limited but they have yet to file their first accounts - so not much background there apart from Bristol based and owned by Anthony Michael PARKER